中文名称: | ARQ-092 | ||||
---|---|---|---|---|---|
英文名称: | ARQ-092 | ||||
别名: | 3-[3-[4-(1-氨基环丁基)苯基]-5-苯基-3H-咪唑并[4,5-b]吡啶-2-基]-2-吡啶胺 Miransertib;3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine | ||||
CAS No: | 1313881-70-7 | 分子式: | C27H24N6 | 分子量: | 432.53 |
CAS No: | 1313881-70-7 | ||||
分子式: | C27H24N6 | ||||
分子量: | 432.53 |
基本信息
产品编号: |
A10984 |
||||
产品名称: |
ARQ-092 |
||||
CAS: |
1313881-70-7 |
储存条件 |
粉末 |
-20℃ |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
6个月 |
||
分子量: |
432.53 |
-20℃ |
1个月 |
||
化学名: |
Miransertib;3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine |
||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
8mg/mL (18.49mM) |
|||
Ethanol |
Insoluble |
||||
Water |
Insoluble |
||||
体内(现配现用): |
请根据您的实验动物和给药⽅式选择适当的溶解⽅案。以下溶解⽅案都请先按照In Vitro⽅式配制澄清的储备液,再依次添加助溶剂:为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的⼯作液,建议您现⽤现配,当天使⽤;以下溶剂前显⽰的百分⽐是指该溶剂在您配制终溶液中的体积占⽐;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的⽅式助溶 1.请依序添加每种溶剂:10% DMSO→40% PEG300→5% Tween-80→45% saline Solubility:≥1.25mg/mL(2.89mM);Clear solution |
||||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
2.3120mL |
11.5602mL |
23.1203mL |
5mM |
0.4624mL |
2.3120mL |
4.6241mL |
10mM |
0.2312mL |
1.1560mL |
2.3120mL |
生物活性
产品描述 |
一种有效的具有口服活性的选择性和变构Akt抑制剂。 |
靶点 |
Akt;Parasite |
体外研究 |
In a large panel of cell lines derived from various tumor types,Miransertib (ARQ-092;Compound 21a) shows potent antiproliferative activity in cell lines containing PIK3CA/PIK3R1 mutations compared to those with wild-type (wt) PIK3CA/PIK3R1 or PTEN loss.Miransertib shows excellent inhibition of p-Akt (S473) and p-Akt (T308) in both AN3CA and A2780 cells.The inhibition of the downstream protein p-PRAS40 (T246) is observed with Miransertib (IC50=0.31μM).Miransertib is markedly effective against intracellular amastigotes of L.donovani or L.amazonensis-infected macrophages.Miransertib also enhances mTOR dependent autophagy in Leishmania-infected macrophages MCE has not independently confirmed the accuracy of these methods.They are for reference only. |
体内研究 |
Miransertib (ARQ-092;Compound 21a) shows good absolute oral bioavailability in rats (5mg/kg) and monkeys (10mg/kg) with F values of 62% and 49%,respectively.The half-life is longer in rats compared to monkeys with t1/2 values of 17h in rats versus 7h in monkeys.The Cmax is 198ng/mL and 258ng/mL and the AUCinf was 5496h•ng/mL and 2960h•ng/mL in rats and monkeys,respectively.Miransertib (ARQ-092;Compound 21a) inhibits tumor growth in a human xenograft mouse model of endometrial adenocarcinoma. |
推荐实验方法(仅供参考)
细胞实验: |
|
Anti-proliferative cellular assays are conducted using the CellTiter Non-Radioactive Cell Proliferation Assay,which utilizes the production of formazan from a tetrazolium compound by live cells.AN3CA and A2780 cells are obtained from the ATCC.AN3CA cells are cultured in DMEM,and A2780 cells are cultured in RPMI.Cells are plated in 96-well plates at 2,000-10,000 cells/well,cultured for 24h,and treated with the test compound for 72h at a final DMSO concentration no greater than 0.5% v/v.PMS stock reagent (0.92mg/mL in DPBS) is diluted 20-fold in MTS stock reagent (2mg/mL in DPBS),and this MTS/PMS mixture is diluted 5-fold into each well of the 96-well plate.The plates are incubated for 3-4h,and the absorbance of formazan is measured at 490nm.The data are normalized to the untreated controls,the dose-response curves are fit to a four-parameter logistic equation,and the IC50 values are determined.All IC50 values reported are the geometric mean of at least two independent determinations. |
动物实验: |
|
Mice SHP2Y279C/+ mice are used.Only male progeny are used for the experiments herein and all mice are maintained on outbred C57BL6/J backgrounds,backcrossed for more than 10 generations.Either vehicle or Miransertib (100mg/kg body weight) is then daily administered by oral gavage for 4 weeks.Administration began at 12 weeks of age (after established hypertrophy is indicated),and continued for 4 weeks,until the mice reach 16 weeks of age.As controls,SHP2+/+ and SHP2Y279C/+ mice are treated with vehicle alone. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )